摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,5,7-tri-O-acetyl-2,6-anhydro-3-deoxy-D-lyxo-hept-2-enononitrile | 120085-63-4

中文名称
——
中文别名
——
英文名称
4,5,7-tri-O-acetyl-2,6-anhydro-3-deoxy-D-lyxo-hept-2-enononitrile
英文别名
[(2R,3R,4R)-3,4-diacetyloxy-6-cyano-3,4-dihydro-2H-pyran-2-yl]methyl acetate
4,5,7-tri-O-acetyl-2,6-anhydro-3-deoxy-D-lyxo-hept-2-enononitrile化学式
CAS
120085-63-4
化学式
C13H15NO7
mdl
——
分子量
297.265
InChiKey
OPOUWJFXZRRHOV-JHJVBQTASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    21
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    112
  • 氢给体数:
    0
  • 氢受体数:
    8

安全信息

  • 安全说明:
    S24/25

SDS

SDS:a3b40b84cdb03bb21d79a9dfc99311b5
查看
Name: 4 5 7-Tri-O-acetyl-2 6-anhydro-3-deoxy-D-l yxo-hept-2-enononitrile Material Safety Data Sheet
Synonym:
CAS: 120085-63-4
Section 1 - Chemical Product MSDS Name:4 5 7-Tri-O-acetyl-2 6-anhydro-3-deoxy-D-l yxo-hept-2-enononitrile Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
120085-63-4 4,5,7-Tri-O-acetyl-2,6-anhydro-3-deoxy unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 120085-63-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid or liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C13H15NO7
Molecular Weight: 297.26

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 120085-63-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4,5,7-Tri-O-acetyl-2,6-anhydro-3-deoxy-D-l yxo-hept-2-enononitrile - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 120085-63-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 120085-63-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 120085-63-4 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4,5,7-tri-O-acetyl-2,6-anhydro-3-deoxy-D-lyxo-hept-2-enononitriledichlorotetrakis(dimethylsulfoxide)ruthenium 、 1-benzyl-1-azonia-3,5-diaza-7-phosphaadamantane choride 作用下, 以 为溶剂, 反应 2.0h, 以72%的产率得到4,5,7-三邻乙酰基-2,6-酐-3-脱氧-d-lyxo-2-氨基庚烯
    参考文献:
    名称:
    在水介质中使用钌配合物将糖基氰化物化学选择性水合为C-糖基甲酰胺
    摘要:
    将[RuCl 2(DMSO)4 ]中的存在Ñ -benzylated 1,3,5-三氮杂-7-磷有效地催化糖基氰化物的水合为相应的甲酰胺衍生物在水或水ñ在105甲基吡咯烷酮溶剂混合物℃。已表明O-乙酰基,O-苯甲酰基和O-苄基保护基,端基溴和叠氮化物取代基以及双键与这些反应条件相容。
    DOI:
    10.1016/j.tetlet.2015.09.040
  • 作为产物:
    描述:
    (2R,3S,4R,5S,6S)-2-(乙酰氧基甲基)-6-氰基四氢-2H-吡喃-3,4,5-三基三乙酸酯 在 molecular sieve 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以 二氯甲烷 为溶剂, 反应 20.0h, 以69%的产率得到4,5,7-tri-O-acetyl-2,6-anhydro-3-deoxy-D-lyxo-hept-2-enononitrile
    参考文献:
    名称:
    3-deoxy-d- lyxo -2-heptulosaric acid(DHA)衍生物的首次合成
    摘要:
    到的3-脱氧-D-甲基糖苷的甲基酯的合成路线来苏-heptulosaric酸(13)由1- cyanogalactal开始2进行说明。后一种物质是通过在二氯甲烷中使用1,8-二氮杂双环[5.4.0]十一烷基-7-烯直接从1中除去乙酸来制备的。
    DOI:
    10.1016/0040-4020(95)00150-7
点击查看最新优质反应信息

文献信息

  • Unprecedented β-manno type thiodisaccharides with a C-glycosylic function by photoinitiated hydrothiolation of 1-C-substituted glycals
    作者:László Lázár、László Juhász、Gyula Batta、Anikó Borbás、László Somsák
    DOI:10.1039/c6nj03751h
    日期:——
    and cyano) substituted glycals with a range of sugar derived thiols gave the corresponding β-manno type 3-deoxy-3-S-disaccharides with full regio- and stereoselectivity. The configuration of the glycals (arabino vs. lyxo) and the size of the protecting groups had no significant effect on the outcome of the transformations. Formation of by-products was tracked down by LCMS studies and correlated with
    自由基hydrothiolation ö -peracylated 1-C-(氨基甲酰基,甲氧基羰基和氰基)取代的烯糖与一系列的糖衍生的硫醇,得到相应的β-甘露键入3-脱氧-3-小号具有完全区域选择性-disaccharides和立体选择性。糖基的构型(阿拉伯糖vs. lyxo)和保护基的大小对转化的结果没有显着影响。通过LCMS研究追踪了副产物的形成,并将其与双键的电子密度相关联,以表明反应对于COOMe,特别是CONH 2基团作为1-C取代基是合成有用的。
  • Remarkable Oxidation Stability of Glycals: Excellent Substrates for Cerium(IV)-Mediated Radical Reactions
    作者:Torsten Linker、Dirk Schanzenbach、Elangovan Elamparuthi、Thomas Sommermann、Werner Fudickar、Viktor Gyóllai、László Somsák、Wolfgang Demuth、Michael Schmittel
    DOI:10.1021/ja8052706
    日期:2008.11.26
    rationale, which might be important for the redox behavior of other allylic systems. Finally, donors and acceptors in the 1-position exert the strongest influence on the oxidation stability, shifting the potentials by almost 1 V and resulting in different follow-up reactions of the cerium(IV)-mediated additions of malonates. It is the remarkable oxidation stability of glycals that makes them valuable
    通过它们在溶液中的氧化还原数据、计算的 HOMO 能量以及添加在硝酸铈 (IV) 铵存在下产生的亲电子自由基的行为,糖醛在氧化条件下的显着稳定性变得明显。获得了高达 2.03 V 与二茂铁的氧化电位,这对于环状烯醇醚来说非常高,但与自由基反应的反应时间密切相关。保护基团对氧化稳定性和糖类的 HOMO 能有很大影响,因为 E(ox) 从 O-甲硅烷基经过 O-苄基转移到 O-乙酰基超过 500 mV。有趣的是,这种效应必须通过 sigma 键传递,甚至高达苯甲酸酯基团的对位,正如碳水化合物中远程取代基的广泛变化所证实的那样。提出了相邻 CO 键的 sigma*-轨道与双键的 HOMO 的有利相互作用作为机械原理,这对于其他烯丙基系统的氧化还原行为可能很重要。最后,1 位的供体和受体对氧化稳定性的影响最大,将电位移动了近 1 V,并导致铈 (IV) 介导的丙二酸酯添加的不同后续反应。糖醛显着的
  • The first general synthesis of 2-<i>C</i>-(β-<scp>d</scp>-glycopyranosyl)pyrimidines and their evaluation as inhibitors of some glycoenzymes
    作者:Eszter Szennyes、Éva Bokor、Peter Langer、Gyöngyi Gyémánt、Tibor Docsa、Ádám Sipos、László Somsák
    DOI:10.1039/c8nj04035d
    日期:——
    A systematic study was performed on the preparation of unknown 2-C-(β-D-glucopyranosyl)pyrimidines. Pinner type cyclisation of O-perbenzylated C-(β-D-glucopyranosyl)formamidine with β-ketoesters, dimethyl malonate, and β-diketone derived α,β-unsaturated β-chloroketones followed by catalytic hydrogenation resulted in various substituted 2-C-(β-D-glucopyranosyl)-pyrimidin-4(3H)-ones, and 2-C-(β-D-glucopyranosyl)-4
    对未知的2- C-(β- D-吡喃葡萄糖基)嘧啶的制备进行了系统的研究。的平纳型环化ö -perbenzylated Ç - (β- d吡喃葡萄糖基)甲脒与β酮酯,丙二酸二甲酯,和β二酮衍生的α,β不饱和β氯酮,接着通过催化氢化导致的各种取代的2- Ç - (β- D-吡喃葡萄糖基)-嘧啶-4(3 H)-一和2- C-(β- D-吡喃葡萄糖基)-4,6-二取代-嘧啶,分别以中等至良好的产率。上述嘧啶衍生物也通过未保护的环闭环而获得。C-(β- D-吡喃葡萄糖基)甲idine具有相同的1,3-二亲电子试剂。此外,还精心设计了一个连续的一锅三步程序,该程序从O-过酰基化的D-氨基葡萄糖基氰化物开始,以可接受的糖总收率(25-94%)得到具有各种糖构型的上述嘧啶的代表。由于所应用的1,3-二亲电子试剂的多功能性,这些合成路线代表了获得目标化合物的第一种可扩展方法。新C-glycopyranosy
  • Preparation of C-(2-deoxyhex/pent-1-enopyranosyl)heterocycles
    作者:Saad H. Mahmoud、László Somsák、István Farkas
    DOI:10.1016/0008-6215(94)84245-0
    日期:1994.2
    )benzothiazoles also gave 2-(per-O-acetyl-2-deoxyhex/pent-1-enopyranosyl)benzothiazole s with DBU. 3-(Per-O-acetylhexo/pentopyranosyl)-[1,2,4]triazolo[4,3-a] pyrimidines rearranged with DBU to the corresponding acetylated 2-glycosyl-[1,2,4]triazolo[1,5-a]pyrimidines. By the reaction of 1-cyano-D-galactal with ammonium azide, 2-(3,4,6-tri-O-acetyl-2-deoxy-D-lyxo-hex-1-enopyranosyl)tetr azole was prepared
    通过用1,8-二氮杂双环[5.4.0]直接从适当的乙酰化2,6-脱水庚烷/己腈中除去乙酸,制得乙酰化的1-氰基葡萄糖(2,6-脱水-3-脱氧庚烷/己-2-烯腈)非质子溶剂中的]十一烷基-7-烯(DBU)。乙酰化的1-氰基-D-半乳糖的氰基与2-氨基硫酚的杂环化导致2-(3,4,6-三-O-乙酰基-2-脱氧-D-lyxo-hex-1-enopyranosyl)苯噻唑。几种2-(全-O-乙酰基己基/戊吡喃糖基)苯并噻唑还与DBU一起产生了2-(全-Oo乙酰基-2-脱氧己基/戊-1-烯吡喃基)苯并噻唑。DBU将3-(Per-O-乙酰基己基/戊吡喃糖基)-[1,2,4]三唑并[4,3-a]嘧啶重排为相应的乙酰化2-糖基-[1,2,4]三唑并[1, 5-a]嘧啶。通过1-氰基-D-半乳糖与叠氮化铵的反应,2-(3,4,
  • Acetylated 1-cyano and 1-cyano-2-hydroxy derivatives of d-galactal and d-arabinal
    作者:László Somsák
    DOI:10.1016/0008-6215(89)85101-8
    日期:1989.12
    Synthese des composes du titre a partir de cyanure de bromo-1 tetra-O-acetyl-2,3,4,6 galactopyranosyle (ou de son analogue D-arabino) traite avec de la poudre de zinc dans l'acide acetique (ou avec du cyanure de mercure dans le nitromethane)
    合成了溴化氰1部分四-O-乙酰基2,3,4,6吡喃半乳糖(或类似物D-阿拉伯糖)的特征氰甲烷的氰化物
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物